NasdaqGS - Delayed Quote USD

GE HealthCare Technologies Inc. (GEHC)

86.24 +0.29 (+0.34%)
At close: April 26 at 4:00 PM EDT
86.25 +0.01 (+0.01%)
After hours: April 26 at 6:41 PM EDT
Key Events
Loading Chart for GEHC
DELL
  • Previous Close 85.95
  • Open 85.36
  • Bid 78.96 x 200
  • Ask 92.94 x 200
  • Day's Range 85.16 - 86.90
  • 52 Week Range 62.35 - 94.50
  • Volume 1,724,108
  • Avg. Volume 3,473,866
  • Market Cap (intraday) 39.354B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 28.37
  • EPS (TTM) 3.04
  • Earnings Date --
  • Forward Dividend & Yield 0.12 (0.14%)
  • Ex-Dividend Date Apr 18, 2024
  • 1y Target Est 95.71

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

www.gehealthcare.com

51,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GEHC

GE completes split into three independent companies

GE completes split into three independent companies

Performance Overview: GEHC

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

GEHC
11.62%
S&P 500
6.92%

1-Year Return

GEHC
7.49%
S&P 500
25.26%

3-Year Return

GEHC
--
S&P 500
30.91%

5-Year Return

GEHC
--
S&P 500
30.91%

Compare To: GEHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GEHC

Valuation Measures

Annual
As of 4/27/2024
  • Market Cap

    39.35B

  • Enterprise Value

    46.72B

  • Trailing P/E

    28.37

  • Forward P/E

    20.12

  • PEG Ratio (5yr expected)

    20.10

  • Price/Sales (ttm)

    2.02

  • Price/Book (mrq)

    5.52

  • Enterprise Value/Revenue

    2.39

  • Enterprise Value/EBITDA

    13.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.02%

  • Return on Assets (ttm)

    6.15%

  • Return on Equity (ttm)

    19.15%

  • Revenue (ttm)

    19.55B

  • Net Income Avi to Common (ttm)

    1.39B

  • Diluted EPS (ttm)

    3.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.49B

  • Total Debt/Equity (mrq)

    134.93%

  • Levered Free Cash Flow (ttm)

    2.6B

Research Analysis: GEHC

Analyst Price Targets

86.00
95.71 Average
86.24 Current
110.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: GEHC

Fair Value

86.24 Current
 

Dividend Score

0 Low
GEHC
Sector Avg.
100 High
 

Hiring Score

0 Low
GEHC
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
GEHC
Sector Avg.
100 High
 

Research Reports: GEHC

  • Analyst Report: GE HealthCare Technologies Inc

    GE HealthCare Technologies., formerly part of General Electric, provides healthcare products and technologies worldwide. The company has four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. GEHC has 50,000 employees.

    Rating
    Price Target
     
  • Market Digest: CBRL, CCL, UPS, GEHC

    Monday Tee Up: Jobs and the Fed

     
  • Weekly Stock List

    The Argus Research Fundamental Universe of Coverage includes approximately 500 leading U.S. and international companies. We cover the waterfront -- from Technology to Utilities from Energy to Healthcare. Generally, we follow the top 200 most widely held stocks, a list we source from our sister company Vickers Stock Research, which collects institutional ownership data from the U.S. Securities and Exchange Commission. From there, we look to identify the next 200-300 emerging U.S. and international companies to add to our list. Our Universe of Coverage is dynamic and growing. We are continually adding stocks to coverage and often get great ideas from our clients. Here are some of our most recent additions.

     
  • Analyst Report: GE HealthCare Technologies Inc

    GE HealthCare Technologies., formerly part of General Electric, provides healthcare products and technologies worldwide. The company has four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. GEHC has 50,000 employees. With a market cap of approximately $31 billion, the shares are in the large-cap category, though they are not yet part of a major index.

    Rating
    Price Target
     

People Also Watch